雜志介紹

Expert Review Of Clinical Immunology雜志介紹

《Expert Review Of Clinical Immunology》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱臨床免疫學專家評論，本刊主要出版、報道醫(yī)學-IMMUNOLOGY領域的研究動態(tài)以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術信息交流，提高行業(yè)發(fā)展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為3.9，最新CiteScore 指數為7.6。

本刊近期中國學者發(fā)表的論文主要有：

• Optimizing the treatment of cytomegalovirus infection in allo-HSCT recipients

  Author: Sun, Yu-Qian; Ma, Rui; Huang, Xiao-Jun

• Innovative treatments for severe uncontrolled chronic rhinosinusitis with nasal polyps

  Author: Huang, Yanran; Zhang, Nan; Bachert, Claus

• Machine learning method for the cellular phenotyping of nasal polyps from multicentre tissue scans

  Author: Ding, Jing; Yue, Changli; Wang, Chengshuo; Liu, Wei; Zhang, Libo; Chen, Bo; Shen, Shen; Piao, Yingshi; Zhang, Luo

• The interaction between innate immunity and oral microbiota in oral diseases

  Author: He, Hongzhi; Hao, Yu; Fan, Yu; Li, Bolei; Cheng, Lei

英文介紹

Expert Review Of Clinical Immunology雜志英文介紹

Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology.

Articles focus on the following key areas:

? Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines

? Performance and benefits of newly approved therapeutic agents

? New diagnostic approaches

? Screening and patient stratification

? Pharmacoeconomic studies

? New therapeutic indications for existing therapies

? Adverse effects, occurrence and reduction

? Prospects for medicines in late-stage trials approaching regulatory approval

? Novel treatment strategies

? Epidemiological studies

? Commentary and comparison of treatment guidelines

Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases.